These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37676771)

  • 21. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
    Ruan Z; Liu C; Guo Y; He Z; Huang X; Jia X; Yang T
    J Med Virol; 2021 Jan; 93(1):389-400. PubMed ID: 32579254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2.
    Machitani M; Takei J; Kaneko MK; Ueki S; Ohashi H; Watashi K; Kato Y; Masutomi K
    Virol J; 2022 Dec; 19(1):213. PubMed ID: 36496472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
    Wang Q; Wu J; Wang H; Gao Y; Liu Q; Mu A; Ji W; Yan L; Zhu Y; Zhu C; Fang X; Yang X; Huang Y; Gao H; Liu F; Ge J; Sun Q; Yang X; Xu W; Liu Z; Yang H; Lou Z; Jiang B; Guddat LW; Gong P; Rao Z
    Cell; 2020 Jul; 182(2):417-428.e13. PubMed ID: 32526208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens.
    Sexton NR; Smith EC; Blanc H; Vignuzzi M; Peersen OB; Denison MR
    J Virol; 2016 Aug; 90(16):7415-7428. PubMed ID: 27279608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against
    Naidu SAG; Mustafa G; Clemens RA; Naidu AS
    J Diet Suppl; 2023; 20(2):254-283. PubMed ID: 34850656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex.
    Yin X; Popa H; Stapon A; Bouda E; Garcia-Diaz M
    J Mol Biol; 2023 Mar; 435(5):167973. PubMed ID: 36690070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli.
    Madru C; Tekpinar AD; Rosario S; Czernecki D; Brûlé S; Sauguet L; Delarue M
    PLoS One; 2021; 16(4):e0250610. PubMed ID: 33914787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The SARS-CoV nsp12 Polymerase Active Site Is Tuned for Large-Genome Replication.
    Campagnola G; Govindarajan V; Pelletier A; Canard B; Peersen OB
    J Virol; 2022 Aug; 96(16):e0067122. PubMed ID: 35924919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants.
    Pitts J; Li J; Perry JK; Du Pont V; Riola N; Rodriguez L; Lu X; Kurhade C; Xie X; Camus G; Manhas S; Martin R; Shi PY; Cihlar T; Porter DP; Mo H; Maiorova E; Bilello JP
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0022222. PubMed ID: 35532238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis.
    Guo S; Lei X; Chang Y; Zhao J; Wang J; Dong X; Liu Q; Zhang Z; Wang L; Yi D; Ma L; Li Q; Zhang Y; Ding J; Liang C; Li X; Guo F; Wang J; Cen S
    Signal Transduct Target Ther; 2022 Dec; 7(1):400. PubMed ID: 36575184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients.
    Lombardo D; Musolino C; Chines V; Caminiti G; Palermo C; Cacciola I; Raffa G; Pollicino T
    Microorganisms; 2023 Dec; 12(1):. PubMed ID: 38276171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.
    Grimes SL; Choi YJ; Banerjee A; Small G; Anderson-Daniels J; Gribble J; Pruijssers AJ; Agostini ML; Abu-Shmais A; Lu X; Darst SA; Campbell E; Denison MR
    mBio; 2023 Aug; 14(4):e0106023. PubMed ID: 37338298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
    Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
    Front Immunol; 2022; 13():844749. PubMed ID: 35464436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2.
    Peng Q; Peng R; Yuan B; Zhao J; Wang M; Wang X; Wang Q; Sun Y; Fan Z; Qi J; Gao GF; Shi Y
    Cell Rep; 2020 Jun; 31(11):107774. PubMed ID: 32531208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of a new monoclonal antibody against SARS-CoV-2 NSP12 (RdRp).
    Meng W; Guo S; Cao S; Shuda M; Robinson-McCarthy LR; McCarthy KR; Shuda Y; Paniz Mondolfi AE; Bryce C; Grimes Z; Sordillo EM; Cordon-Cardo C; Li P; Zhang H; Perlman S; Guo H; Gao SJ; Chang Y; Moore PS
    J Med Virol; 2023 Jan; 95(1):e28246. PubMed ID: 36271490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations.
    Periwal N; Rathod SB; Sarma S; Johar GS; Jain A; Barnwal RP; Srivastava KR; Kaur B; Arora P; Sood V
    Microbiol Spectr; 2022 Oct; 10(5):e0121922. PubMed ID: 36069583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
    Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation.
    Yang L; Zeng XT; Luo RH; Ren SX; Liang LL; Huang QX; Tang Y; Fan H; Ren HY; Zhang WJ; Zheng YT; Cheng W
    J Med Virol; 2024 Jan; 96(1):e29396. PubMed ID: 38235848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide inhibitors derived from the nsp7 and nsp8 cofactors of nsp12 targeting different substrate binding sites of nsp12 of the SARS-CoV-2.
    Jena NR; Pant S
    J Biomol Struct Dyn; 2024 Aug; 42(13):7077-7089. PubMed ID: 37434315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.
    Showers WM; Leach SM; Kechris K; Strong M
    Infect Genet Evol; 2022 Jan; 97():105153. PubMed ID: 34801754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.